1. Home
  2. BGC vs BLLN Comparison

BGC vs BLLN Comparison

Compare BGC & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGC Group Inc.

BGC

BGC Group Inc.

HOLD

Current Price

$9.03

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$87.17

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGC
BLLN
Founded
1945
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.9B
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
BGC
BLLN
Price
$9.03
$87.17
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$14.50
$137.83
AVG Volume (30 Days)
2.0M
259.9K
Earning Date
02-12-2026
12-09-2025
Dividend Yield
0.88%
N/A
EPS Growth
36.46
N/A
EPS
0.33
N/A
Revenue
$2,640,884,000.00
$254,136,000.00
Revenue This Year
$36.34
$98.01
Revenue Next Year
$11.45
$35.84
P/E Ratio
$27.38
N/A
Revenue Growth
24.59
254.30
52 Week Low
$7.24
$80.51
52 Week High
$10.96
$138.70

Technical Indicators

Market Signals
Indicator
BGC
BLLN
Relative Strength Index (RSI) 54.68 N/A
Support Level $8.59 N/A
Resistance Level $8.89 N/A
Average True Range (ATR) 0.20 0.00
MACD -0.00 0.00
Stochastic Oscillator 66.67 0.00

Price Performance

Historical Comparison
BGC
BLLN

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About BLLN BillionToOne Inc.

BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.

Share on Social Networks: